[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]
IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
1997 | 0 | 0.24 | 0 | 0 | 10 | 10 | 17 | 0 | 0 | 0 | 0 | 0 | 0.11 | |||||
1998 | 0 | 0.28 | 0 | 0 | 12 | 22 | 8 | 0 | 10 | 10 | 0 | 0 | 0.13 | |||||
2000 | 0 | 0.36 | 0.03 | 0.05 | 9 | 31 | 15 | 1 | 6 | 12 | 22 | 1 | 0 | 0 | 0.16 | |||
2001 | 0 | 0.38 | 0.09 | 0.1 | 3 | 34 | 4 | 3 | 9 | 9 | 31 | 3 | 2 | 66.7 | 0 | 0.17 | ||
2003 | 0 | 0.44 | 0.1 | 0.08 | 5 | 39 | 13 | 4 | 16 | 3 | 24 | 2 | 1 | 25 | 0 | 0.22 | ||
2004 | 0.2 | 0.49 | 0.08 | 0.12 | 1 | 40 | 3 | 3 | 19 | 5 | 1 | 17 | 2 | 0 | 0 | 0.22 | ||
2005 | 0.17 | 0.5 | 0.04 | 0.06 | 7 | 47 | 14 | 2 | 21 | 6 | 1 | 18 | 1 | 0 | 0 | 0.23 | ||
2006 | 0 | 0.5 | 0.17 | 0.13 | 62 | 109 | 122 | 18 | 39 | 8 | 16 | 2 | 15 | 83.3 | 13 | 0.21 | 0.22 | |
2007 | 0.09 | 0.46 | 0.08 | 0.09 | 38 | 147 | 93 | 12 | 51 | 69 | 6 | 75 | 7 | 5 | 41.7 | 2 | 0.05 | 0.2 |
2008 | 0.07 | 0.49 | 0.07 | 0.08 | 22 | 169 | 256 | 11 | 62 | 100 | 7 | 113 | 9 | 4 | 36.4 | 0 | 0.23 | |
2009 | 0.18 | 0.47 | 0.11 | 0.13 | 28 | 197 | 80 | 22 | 84 | 60 | 11 | 130 | 17 | 8 | 36.4 | 1 | 0.04 | 0.24 |
2010 | 0.42 | 0.48 | 0.22 | 0.26 | 33 | 230 | 79 | 50 | 134 | 50 | 21 | 157 | 41 | 11 | 22 | 0 | 0.21 | |
2011 | 0.16 | 0.52 | 0.18 | 0.17 | 32 | 262 | 119 | 48 | 182 | 61 | 10 | 183 | 32 | 16 | 33.3 | 5 | 0.16 | 0.24 |
2012 | 0.42 | 0.52 | 0.36 | 0.39 | 93 | 355 | 178 | 128 | 310 | 65 | 27 | 153 | 60 | 64 | 50 | 26 | 0.28 | 0.22 |
2013 | 0.32 | 0.56 | 0.28 | 0.32 | 96 | 451 | 429 | 126 | 436 | 125 | 40 | 208 | 66 | 37 | 29.4 | 28 | 0.29 | 0.24 |
2014 | 0.2 | 0.55 | 0.2 | 0.19 | 110 | 561 | 343 | 112 | 548 | 189 | 37 | 282 | 54 | 29 | 25.9 | 18 | 0.16 | 0.23 |
2015 | 0.31 | 0.55 | 0.29 | 0.28 | 105 | 666 | 339 | 191 | 739 | 206 | 64 | 364 | 103 | 31 | 16.2 | 16 | 0.15 | 0.23 |
2016 | 0.28 | 0.53 | 0.26 | 0.28 | 133 | 799 | 249 | 206 | 945 | 215 | 61 | 436 | 121 | 36 | 17.5 | 12 | 0.09 | 0.21 |
2017 | 0.29 | 0.54 | 0.27 | 0.26 | 116 | 915 | 250 | 250 | 1196 | 238 | 68 | 537 | 138 | 60 | 24 | 28 | 0.24 | 0.22 |
2018 | 0.27 | 0.56 | 0.29 | 0.31 | 128 | 1043 | 157 | 303 | 1499 | 249 | 67 | 560 | 174 | 40 | 13.2 | 13 | 0.1 | 0.24 |
2019 | 0.29 | 0.58 | 0.32 | 0.27 | 132 | 1175 | 180 | 373 | 1872 | 244 | 71 | 592 | 160 | 60 | 16.1 | 35 | 0.27 | 0.23 |
2020 | 0.24 | 0.7 | 0.33 | 0.29 | 118 | 1293 | 66 | 424 | 2296 | 260 | 62 | 614 | 179 | 34 | 8 | 13 | 0.11 | 0.33 |
2021 | 0.23 | 0.87 | 0.3 | 0.23 | 114 | 1407 | 46 | 425 | 2721 | 250 | 58 | 627 | 147 | 38 | 8.9 | 18 | 0.16 | 0.32 |
2022 | 0.21 | 1 | 0.27 | 0.24 | 120 | 1527 | 19 | 416 | 3137 | 232 | 48 | 608 | 146 | 25 | 6 | 22 | 0.18 | 0.31 |
IF: | Two years Impact Factor: C2Y / D2Y |
AIF: | Average Impact Factor for all series in RePEc in year y |
CIF: | Cumulative impact factor |
IF5: | Five years Impact Factor: C5Y / D5Y |
DOC: | Number of documents published in year y |
CDO: | Cumulative number of documents published until year y |
CIT: | Number of citations to papers published in year y |
NCI: | Number of citations in year y |
CCU: | Cumulative number of citations to papers published until year y |
D2Y: | Number of articles published in y-1 plus y-2 |
C2Y: | Cites in y to articles published in y-1 plus y-2 |
D5Y: | Number of articles published in y-1 until y-5 |
C5Y: | Cites in y to articles published in y-1 until y-5 |
SC: | selft citations in y to articles published in y-1 plus y-2 |
%SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
CiY: | Cites in year y to documents published in year y |
II: | Immediacy Index: CiY / Documents. |
AII: | Average Immediacy Index for series in RePEc in year y |
# | Year | Title | Cited |
---|---|---|---|
1 | 2013 | Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Greenberg, Dan ; Carswell, Chris ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367. Full description at Econpapers || Download paper | 239 |
2 | 2008 | Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. Full description at Econpapers || Download paper | 190 |
3 | 2014 | Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino ; Moro, Domenico ; Petrou, Stavros. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902. Full description at Econpapers || Download paper | 83 |
4 | 2019 | Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Vass, Caroline ; Ellis, Alan R ; Bekker-Grob, Esther W ; Soekhai, Vikas. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2. Full description at Econpapers || Download paper | 68 |
5 | 2017 | Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4. Full description at Econpapers || Download paper | 57 |
6 | 2016 | Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9. Full description at Econpapers || Download paper | 43 |
7 | 2015 | The Epidemiology of Obesity: A Big Picture. (2015). Hruby, Adela ; Hu, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:673-689. Full description at Econpapers || Download paper | 41 |
8 | 2015 | The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Suhrcke, Marc ; Archangelidi, Olga ; Seuring, Till. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831. Full description at Econpapers || Download paper | 35 |
9 | Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33. Full description at Econpapers || Download paper | 33 | |
10 | 2014 | A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170. Full description at Econpapers || Download paper | 32 |
11 | 2013 | How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119. Full description at Econpapers || Download paper | 30 |
12 | 2014 | Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965. Full description at Econpapers || Download paper | 28 |
13 | 2016 | EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark ; Luo, Nan. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1. Full description at Econpapers || Download paper | 27 |
14 | 2012 | Golimumab for the Treatment of Psoriatic Arthritis. (2012). Sculpher, Mark ; EPSTEIN, DAVID ; Bruce, Ian ; Yang, Huiqin ; Craig, Dawn ; Woolacott, Nerys ; Bojke, Laura ; Light, Kate . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:4:p:257-270. Full description at Econpapers || Download paper | 26 |
15 | 2009 | Cost Effectiveness in Low- and Middle-Income Countries. (2009). Walker, Damian ; Goodman, Catherine ; Mills, Anne ; Shillcutt, Samuel . In: PharmacoEconomics. RePEc:spr:pharme:v:27:y:2009:i:11:p:903-917. Full description at Econpapers || Download paper | 25 |
16 | 2015 | Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Meyerhoefer, Chad ; Cawley, John ; Biener, Adam ; Hammer, Mette ; Wintfeld, Neil . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722. Full description at Econpapers || Download paper | 25 |
17 | 2015 | The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration. (2015). Gray, Alastair ; Froud, Robert ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver ; Petrou, Stavros ; Oppe, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:993-1011. Full description at Econpapers || Download paper | 23 |
18 | 2014 | How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344. Full description at Econpapers || Download paper | 21 |
19 | 2014 | Preferences for Oral Anticoagulants in Atrial Fibrillation: a BestâBest Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127. Full description at Econpapers || Download paper | 19 |
20 | 2017 | The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; del Pozo-Rubio, Raul ; Pea-Longobardo, Luz Maria ; Trapero-Bertran, Marta ; Oliva-Moreno, Juan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y. Full description at Econpapers || Download paper | 19 |
21 | 2014 | The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86. Full description at Econpapers || Download paper | 18 |
22 | 2018 | German Value Set for the EQ-5D-5L. (2018). Graf von der Schulenburg, Johann ; Greiner, Wolfgang ; J-Matthias Graf von der Schulenburg, ; Ludwig, Kristina. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8. Full description at Econpapers || Download paper | 18 |
23 | 2015 | A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028. Full description at Econpapers || Download paper | 17 |
24 | 2015 | Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Arnberg, Karl ; Nilsson, Fredrik. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236. Full description at Econpapers || Download paper | 17 |
25 | 2014 | Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime ; Neasham, David ; Lanitis, Tereza . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365. Full description at Econpapers || Download paper | 17 |
26 | 2015 | Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135. Full description at Econpapers || Download paper | 17 |
27 | 2018 | Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Cheng, Terence ; Ali, Hossein Haji ; Edney, Laura Catherine ; Karnon, Jonathan. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2. Full description at Econpapers || Download paper | 16 |
28 | 2017 | International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Hout, Ben ; Chevrou-Severac, Helene ; Zouraq, Ismail Azzabi ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y. Full description at Econpapers || Download paper | 16 |
29 | 2011 | Do Productivity Costs Matter?. (2011). Brouwer, Werner ; Krol, Marieke ; Koopmanschap, Marc ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:601-619. Full description at Econpapers || Download paper | 16 |
30 | 2015 | Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Crausaz, Steffan ; Clement, Fiona ; Elshaug, Adam ; Lopert, Ruth ; Pearson, Sallie-Anne ; Choudhury, Moni ; Garner, Sarah ; Godman, Brian. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924. Full description at Econpapers || Download paper | 15 |
31 | 2013 | Operationalizing Value-Based Pricing of Medicines. (2013). Towse, Adrian ; Devlin, Nancy ; Sussex, Jon. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:1-10. Full description at Econpapers || Download paper | 14 |
32 | 2018 | A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D. (2018). Feng, You-Shan ; Kohlmann, Thomas ; Janssen, Mathieu F ; Buchholz, Ines. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0642-5. Full description at Econpapers || Download paper | 14 |
33 | 2014 | Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010. (2014). Klemp, Marianne ; Olsen, Jan ; Hagen, Gunhild ; Movik, Espen ; Hamidi, Vida ; Wisloff, Torbjorn. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:367-375. Full description at Econpapers || Download paper | 14 |
34 | 2010 | Using Conjoint Analysis and Choice Experiments to Estimate QALY Values. (2010). Flynn, Terry. In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:9:p:711-722. Full description at Econpapers || Download paper | 14 |
35 | Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Muszbek, Noemi ; Ishak, K. ; Benedict, Agnes. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675. Full description at Econpapers || Download paper | 13 | |
36 | 2012 | Losing Sight of the Wood for the Trees. (2012). Peasgood, Tessa ; Dolan, Paul ; Lee, Henry. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:11:p:1035-1049. Full description at Econpapers || Download paper | 13 |
37 | 2018 | Discounting in Economic Evaluations. (2018). Claxton, Karl ; Brouwer, Werner ; Attema, Arthur. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z. Full description at Econpapers || Download paper | 13 |
38 | 2008 | Cost-Effectiveness Analyses of Vaccination Programmes. (2008). Kim, Sun-Young ; Goldie, Sue. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:3:p:191-215. Full description at Econpapers || Download paper | 12 |
39 | 2016 | Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial. (2016). Kim, Jane J ; Verguet, Stephane ; Jamison, Dean T. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0414-z. Full description at Econpapers || Download paper | 12 |
40 | 2006 | Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996â2003. (2006). Huang, Yu-Tung ; Chen, Sun-Bing ; Yang, Ming-Chin ; Liu, Chien-Hsiang ; Lee, Yue-Chune. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:891-902. Full description at Econpapers || Download paper | 12 |
41 | 2007 | Rates and Probabilities in Economic Modelling. (2007). Fleurence, Rachael ; Hollenbeak, Christopher . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:1:p:3-6. Full description at Econpapers || Download paper | 12 |
42 | The Impact of the Urban Resident Basic Medical Insurance on Health Services Utilisation in China. (2014). Chen, Gang ; Liu, Gordon ; Xu, Fei. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:3:p:277-292. Full description at Econpapers || Download paper | 12 | |
43 | 2006 | Using Discrete Choice Experiments within a Cost-Benefit Analysis Framework. (2006). McIntosh, Emma. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:855-868. Full description at Econpapers || Download paper | 12 |
44 | 1997 | Guidelines for Pharmacoeconomic Studies. (1997). Russell, Louise ; Siegel, Joanna ; Torrance, George ; Luce, Bryan ; Weinstein, Milton ; Gold, Marthe . In: PharmacoEconomics. RePEc:spr:pharme:v:11:y:1997:i:2:p:159-168. Full description at Econpapers || Download paper | 11 |
45 | 2000 | Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio. (2000). Montmartin, Jacques ; Stevens, John ; OHagan, Anthony . In: PharmacoEconomics. RePEc:spr:pharme:v:17:y:2000:i:4:p:339-349. Full description at Econpapers || Download paper | 11 |
46 | 2016 | Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment. (2016). Angelis, Aris ; Kanavos, Panos. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0370-z. Full description at Econpapers || Download paper | 11 |
47 | 2017 | Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature. (2017). Krahn, Murray ; Fenwick, Elisabeth ; Koffijberg, Hendrik ; Ijzerman, Maarten J. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0509-1. Full description at Econpapers || Download paper | 11 |
48 | 2018 | Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Luo, Nan ; Bonsel, Gouke J ; Janssen, Mathieu F. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8. Full description at Econpapers || Download paper | 11 |
49 | 2019 | Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. (2019). Deshpande, Abhishek ; Zhang, LU ; Nghiem, Van T ; Chiyaka, Edward T ; Le, Phuc ; Mullen, Patricia Dolan. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0735-1. Full description at Econpapers || Download paper | 11 |
50 | 2012 | Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001â7. (2012). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:197-211. Full description at Econpapers || Download paper | 11 |
# | Year | Title | Cited |
---|---|---|---|
1 | 2008 | Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. Full description at Econpapers || Download paper | 58 |
2 | 2019 | Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Vass, Caroline ; Ellis, Alan R ; Bekker-Grob, Esther W ; Soekhai, Vikas. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2. Full description at Econpapers || Download paper | 47 |
3 | 2013 | Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Greenberg, Dan ; Carswell, Chris ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367. Full description at Econpapers || Download paper | 43 |
4 | 2014 | Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino ; Moro, Domenico ; Petrou, Stavros. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902. Full description at Econpapers || Download paper | 38 |
5 | 2015 | The Epidemiology of Obesity: A Big Picture. (2015). Hruby, Adela ; Hu, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:673-689. Full description at Econpapers || Download paper | 27 |
6 | 2017 | Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4. Full description at Econpapers || Download paper | 26 |
7 | 2016 | Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9. Full description at Econpapers || Download paper | 25 |
8 | 2018 | A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D. (2018). Feng, You-Shan ; Kohlmann, Thomas ; Janssen, Mathieu F ; Buchholz, Ines. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0642-5. Full description at Econpapers || Download paper | 12 |
9 | 2015 | The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Suhrcke, Marc ; Archangelidi, Olga ; Seuring, Till. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831. Full description at Econpapers || Download paper | 12 |
10 | 2018 | German Value Set for the EQ-5D-5L. (2018). Graf von der Schulenburg, Johann ; Greiner, Wolfgang ; J-Matthias Graf von der Schulenburg, ; Ludwig, Kristina. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8. Full description at Econpapers || Download paper | 11 |
11 | 2014 | Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965. Full description at Econpapers || Download paper | 11 |
12 | 2016 | EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark ; Luo, Nan. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1. Full description at Econpapers || Download paper | 11 |
13 | 2019 | Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. (2019). Deshpande, Abhishek ; Zhang, LU ; Nghiem, Van T ; Chiyaka, Edward T ; Le, Phuc ; Mullen, Patricia Dolan. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0735-1. Full description at Econpapers || Download paper | 10 |
14 | 2021 | The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018). (2021). Simes, Mark ; Sisitsky, Tammy ; Fournier, Andree-Anne ; Greenberg, Paul E ; Kessler, Ronald C ; Koenigsberg, Sarah H ; Berman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01019-4. Full description at Econpapers || Download paper | 9 |
15 | 2014 | A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170. Full description at Econpapers || Download paper | 9 |
16 | 2013 | How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119. Full description at Econpapers || Download paper | 9 |
17 | 2017 | International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Hout, Ben ; Chevrou-Severac, Helene ; Zouraq, Ismail Azzabi ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y. Full description at Econpapers || Download paper | 9 |
18 | 2018 | Discounting in Economic Evaluations. (2018). Claxton, Karl ; Brouwer, Werner ; Attema, Arthur. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z. Full description at Econpapers || Download paper | 8 |
19 | 2014 | Preferences for Oral Anticoagulants in Atrial Fibrillation: a BestâBest Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127. Full description at Econpapers || Download paper | 8 |
20 | 2017 | Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature. (2017). Krahn, Murray ; Fenwick, Elisabeth ; Koffijberg, Hendrik ; Ijzerman, Maarten J. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0509-1. Full description at Econpapers || Download paper | 7 |
21 | 2019 | Economic Spillover Effects of Intensive Unpaid Caregiving. (2019). Van Houtven, Courtney ; Tanielian, Terri ; Jacobs, Josephine C ; Ramchand, Rajeev. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00784-7. Full description at Econpapers || Download paper | 6 |
22 | 2019 | Spillover Effects on Caregiversâ and Family Membersâ Utility: A Systematic Review of the Literature. (2019). Prosser, Lisa A ; James, Lyndon P ; Wittenberg, Eve. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00768-7. Full description at Econpapers || Download paper | 6 |
23 | 2018 | Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Cheng, Terence ; Ali, Hossein Haji ; Edney, Laura Catherine ; Karnon, Jonathan. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2. Full description at Econpapers || Download paper | 6 |
24 | 2019 | Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe. (2019). Niewada, Maciej ; Graczyk, Katarzyna ; Jakubczyk, Micha ; Golicki, Dominik. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:9:d:10.1007_s40273-019-00811-7. Full description at Econpapers || Download paper | 6 |
25 | 2017 | The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; del Pozo-Rubio, Raul ; Pea-Longobardo, Luz Maria ; Trapero-Bertran, Marta ; Oliva-Moreno, Juan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y. Full description at Econpapers || Download paper | 6 |
26 | 2014 | How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344. Full description at Econpapers || Download paper | 6 |
27 | 2015 | Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Arnberg, Karl ; Nilsson, Fredrik. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236. Full description at Econpapers || Download paper | 6 |
28 | 2016 | Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial. (2016). Kim, Jane J ; Verguet, Stephane ; Jamison, Dean T. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0414-z. Full description at Econpapers || Download paper | 6 |
29 | 2018 | Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Luo, Nan ; Bonsel, Gouke J ; Janssen, Mathieu F. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8. Full description at Econpapers || Download paper | 6 |
30 | 2019 | The Use of Risk-Sharing Contracts in Healthcare: Theoretical and Empirical Assessments. (2019). Rodriguez-Ibeas, Roberto ; Lorente, Reyes ; Juarez-Castello, Carmelo ; Antonanzas, Fernando. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:12:d:10.1007_s40273-019-00838-w. Full description at Econpapers || Download paper | 6 |
31 | 2014 | Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010. (2014). Klemp, Marianne ; Olsen, Jan ; Hagen, Gunhild ; Movik, Espen ; Hamidi, Vida ; Wisloff, Torbjorn. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:367-375. Full description at Econpapers || Download paper | 5 |
32 | 2015 | Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. (2015). Gray, Alastair ; Froud, Robert ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver ; Petrou, Stavros ; Oppe, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:985-991. Full description at Econpapers || Download paper | 5 |
33 | 2021 | What are the Economic Costs to Society Attributable to Alcohol Use? A Systematic Review and Modelling Study. (2021). Kilian, Carolin ; Carr, Sinclair ; Hassan, Syed Ahmed ; Manthey, Jakob ; Rehm, Jurgen ; Kuitunen-Paul, Soren. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:7:d:10.1007_s40273-021-01031-8. Full description at Econpapers || Download paper | 5 |
34 | 2018 | Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues. (2018). Danzon, Patricia. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0696-4. Full description at Econpapers || Download paper | 5 |
35 | 2015 | A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028. Full description at Econpapers || Download paper | 5 |
36 | 2013 | Disutility of Illness for Caregivers and Families: A Systematic Review of the Literature. (2013). Prosser, Lisa ; Wittenberg, Eve. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:6:p:489-500. Full description at Econpapers || Download paper | 5 |
37 | 2015 | The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration. (2015). Gray, Alastair ; Froud, Robert ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver ; Petrou, Stavros ; Oppe, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:993-1011. Full description at Econpapers || Download paper | 5 |
38 | 2022 | Value Set for the EQ-5D-Y-3L in Hungary. (2022). Brodszky, Valentin ; Finch, Aureliano Paolo ; Yang, Zhihao ; Bato, Alex ; Ruzsa, Gabor ; Rencz, Fanni. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01190-2. Full description at Econpapers || Download paper | 5 |
39 | 2022 | A Value Set for the EQ-5D-Y-3L in the Netherlands. (2022). Finch, Aureliano Paolo ; Stalmeier, Peep ; Lipman, Stefan ; Essers, Brigitte ; Sajjad, Ayesha ; Roudijk, Bram. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01192-0. Full description at Econpapers || Download paper | 5 |
40 | 2015 | Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135. Full description at Econpapers || Download paper | 5 |
41 | 2011 | Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33. Full description at Econpapers || Download paper | 5 |
42 | 2017 | Performance-Based Risk-Sharing Arrangements: An Updated International Review. (2017). Garrison, Louis P ; Chen, Shuxian ; Carlson, Josh J. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:10:d:10.1007_s40273-017-0535-z. Full description at Econpapers || Download paper | 5 |
43 | 2019 | The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra. (2019). Brouwer, Werner. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-018-0730-6. Full description at Econpapers || Download paper | 4 |
44 | 2015 | A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE). (2015). Viney, Rosalie ; Feeny, David ; Devlin, Nancy ; Krabbe, Paul ; Pickard, A ; Xie, Feng ; Revicki, Dennis. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:867-877. Full description at Econpapers || Download paper | 4 |
45 | 2017 | Simulation Modelling in Healthcare: An Umbrella Review of Systematic Literature Reviews. (2017). Hughes, Ruby ; Brennan, Alan ; Thokala, Praveen ; Salleh, Syed ; Booth, Andrew. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0523-3. Full description at Econpapers || Download paper | 4 |
46 | 2022 | Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. (2022). Staniszewska, Sophie ; Bekker-Grob, Esther ; Pwu, Raoh-Fang ; Augustovski, Federico ; Petrou, Stavros ; Drummond, Michael ; Mullins, Daniel C ; Husereau, Don ; Mauskopf, Josephine ; Loder, Elizabeth ; Greenberg, Dan ; Chaiyakunapruk, Nathorn ; Caulley, Lisa ; Carswell, Chris ; Briggs, Andrew H. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:6:d:10.1007_s40273-021-01112-8. Full description at Econpapers || Download Economic Burden of Anxiety Disorders: A Systematic Review and Meta-Analysis. (2020). Konig, Hannah ; Konnopka, Alexander. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:1:d:10.1007_s40273-019-00849-7. Full description at Econpapers || Download paper | 4 |
48 | 2021 | EQ-5D-Y Value Set for Slovenia. (2021). Ogorevc, Marko ; Rupel, Valentina Prevolnik. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:4:d:10.1007_s40273-020-00994-4. Full description at Econpapers || Download paper | 4 |
49 | 2017 | The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. (2017). Haycox, Alan ; Markovic-Pekovic, Vanda ; Bochenek, Tomasz ; Godman, Brian ; Mardare, Ileana ; Arja, Dina ; Bonanno, Patricia Vella ; Loblova, Olga ; Ferrario, Alessandra ; Kanavos, Panos ; Laidmae, Erki ; Jakupi, Arianit ; Voncina, Luka ; Hoxha, Iris ; Tomek, Dominik ; Greiit-Kuprijanov, Ieva ; Pomorski, Maciej ; Furst, Jurij ; Petrova, Guenka ; Dimitrova, Maria ; Novakovic, Tanja ; Danko, David ; Meshkov, Dmitry ; Ati, Tarik. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:12:d:10.1007_s40273-017-0559-4. | 4 |
50 | 2020 | Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines. (2020). Federici, Carlo ; Dams, Florian ; Ciani, Oriana ; Grigore, Bogdan ; Taylor, Rod S ; Zemplenyi, Antal ; Shatrov, Kosta ; Rabbe, Stefan ; Mollenkamp, Meilin ; Groot, Saskia. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:10:d:10.1007_s40273-020-00935-1. Full description at Econpapers || Download paper | 4 |
Year | Title | |
---|---|---|
2022 | An approach to quantify parameter uncertainty in early assessment of novel health technologies. (2022). Blankart, Carl Rudolf ; Berns, Cassandra ; Federici, Carlo ; Iskandar, Rowan. In: Health Economics. RePEc:wly:hlthec:v:31:y:2022:i:s1:p:116-134. Full description at Econpapers || Download paper | |
2022 | Coverage with evidence development for medical devices in Europe: Can practice meet theory?. (2022). Brouwer, Werner ; Kovacs, Sandor ; Kalo, Zoltan ; Ciani, Oriana ; Blankart, Carl Rudolf ; Torbica, Aleksandra ; Reckersdroog, Vivian ; Federici, Carlo ; Drummond, Michael. In: Health Economics. RePEc:wly:hlthec:v:31:y:2022:i:s1:p:179-194. Full description at Econpapers || Download paper | |
2022 | Development of a framework and decision tool for the evaluation of health technologies based on surrogate endpoint evidence. (2022). Taylor, Rod S ; Grigore, Bogdan ; Ciani, Oriana. In: Health Economics. RePEc:wly:hlthec:v:31:y:2022:i:s1:p:44-72. Full description at Econpapers || Download paper | |
2022 | Pushing the boundaries of evaluation, diffusion, and use of medical devices in Europe: Insights from the COMED project. (2022). Drummond, Mike ; Schreyogg, Jonas ; Tarricone, Rosanna ; Torbica, Aleksandra. In: Health Economics. RePEc:wly:hlthec:v:31:y:2022:i:s1:p:1-9. Full description at Econpapers || Download paper | |
2022 | Hospitalization costs of coronaviruses diseases in upper-middle-income countries: A systematic review. (2022). Ferla, Laura Jantsch ; de Assis, Felipe Sebastio ; Pereira, Ana Carolina ; da Rocha, Aline Pereira ; Moa, Giulia Fernandes ; Ramalho, Gabriel Sodre ; Lucchetta, Rosa Camila ; Leite, Johnny Wallef ; Saconato, Humberto ; Rocha-Filho, Cesar Ramos ; Correa, Luci ; de Carvalho, Patricia. In: PLOS ONE. RePEc:plo:pone00:0265003. Full description at Econpapers || Download paper | |
2022 | An Integrated PharmacokineticâPharmacodynamicâPharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia. (2022). Wang, Xiaofeng ; Kraan, Carla W ; Houwing, Natalie ; Piena, Marjanne A ; Bennison, Craig ; Mallikaarjun, Suresh ; Duffy, Ruth A ; Waters, Heidi. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:1:d:10.1007_s40273-021-01077-8. Full description at Econpapers || Download paper | |
2022 | . Full description at Econpapers || Download paper | |
2022 | . Full description at Econpapers || Download paper | |
2022 | The health cost of reducing hospital bed capacity. (2022). Henriksson, Martin ; Siverskog, Jonathan. In: Social Science & Medicine. RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622007055. Full description at Econpapers || Download paper | |
2022 | Amortization of gene replacement therapies: A health policy analysis exploring a mechanism for mitigating budget impact of high-cost treatments. (2022). Wang, Yitong ; Saal, Gauri ; Wasem, Juergen ; Simoens, Steven ; Garrison, Louis P ; Toumi, Mondher ; Malone, Daniel ; Dabbous, Monique ; Sola-Morales, Oriol ; von der Schulenburg, Johann-Matthias Graf ; Annemans, Lieven ; Franois, Clement ; Huerta, Jose Luis. In: Health Policy. RePEc:eee:hepoli:v:126:y:2022:i:1:p:49-59. Full description at Econpapers || Download Utility maximization versus regret minimization in health choice behavior: Evidence from four datasets. (2022). Quaife, Matthew ; Regier, Dean A ; Wordsworth, Sarah ; Vasavada, Vrinda ; Buckell, John. In: Health Economics. RePEc:wly:hlthec:v:31:y:2022:i:2:p:363-381. Full description at Econpapers || Download paper | |
2022 | . Full description at Econpapers || Download paper | |
2022 | . Full description at Econpapers || Download paper | |
2022 | The benefit of an ambulant psychiatric rehabilitation program in Vienna, Austria: an uncontrolled repeated measures study. (2022). Rauner, Marion ; Senft, Birgit ; Schosser, Alexandra. In: Central European Journal of Operations Research. RePEc:spr:cejnor:v:30:y:2022:i:1:d:10.1007_s10100-021-00773-2. Full description at Econpapers || Download paper | |
2022 | An Efficient Approach for Optimizing the Cost-effective Individualized Treatment Rule Using Conditional Random Forest. (2022). Greene, Tom H ; Xu, Yizhe ; Shen, Jincheng ; Moran, Andrew S ; Weintraub, William S ; Kolm, Paul ; Zhang, Zugui ; Bellows, Brandon K ; Bress, Adam P. In: Papers. RePEc:arx:papers:2204.10971. Full description at Econpapers || Download paper | |
2022 | Public health policies for the common interest: rethinking EU statesâ incentives strategies when a pandemic reshuffles all interests. (2022). Gol-Montserrat, Jordi ; Espin, Jaime ; Mestre-Ferrandiz, Jorge ; Llano, Juan ; Bringas, Carlos. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:23:y:2022:i:3:d:10.1007_s10198-021-01341-w. Full description at Econpapers || Download paper | |
2022 | Pharmaceutical net price transparency across european markets: Insights from a multi-agent simulation model. (2022). van Dyck, Walter ; Swoboda, Torben ; Riccaboni, Massimo. In: Health Policy. RePEc:eee:hepoli:v:126:y:2022:i:6:p:534-540. Full description at Econpapers || Download paper | |
2022 | How value-based policy interventions influence price negotiations for new medicines: An experimental approach and initial evidence. (2022). Boes, Stefan ; Wettstein, Dominik J. In: Health Policy. RePEc:eee:hepoli:v:126:y:2022:i:2:p:112-121. Full description at Econpapers || Download paper | |
2022 | Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis. (2022). Ho, Carlos King ; Hang, Prudence Wing ; Luo, Nan ; Yin, Jason Pui ; Lin, Jiaer. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:23:y:2022:i:8:d:10.1007_s10198-022-01435-z. Full description at Econpapers || Download paper | |
2022 | Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values. (2022). Stolk, Elly ; Purba, Fredrick Dermawan ; Roudijk, Bram ; Fitriana, Titi Sahidah. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01210-1. Full description at Econpapers || Download paper | |
2022 | An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration. (2022). Jommi, Claudio ; Roudijk, Bram ; Ciani, Oriana ; Meregaglia, Michela ; Finch, Aureliano Paolo. In: Social Science & Medicine. RePEc:eee:socmed:v:292:y:2022:i:c:s0277953621008510. Full description at Econpapers || Download paper | |
2022 | Determinants of willingness to pay for health services: a systematic review of contingent valuation studies. (2022). Leiter, Andrea M ; Siebert, Uwe ; Flatscher-Thoeni, Magdalena ; Steigenberger, Caroline. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:23:y:2022:i:9:d:10.1007_s10198-022-01437-x. Full description at Econpapers || Download paper | |
2022 | An integrated framework for assessment of smart city resilience. (2022). Javanmardi, Ahad ; Ghaedi, Khaled ; Dianat, Heiman ; Baghersad, Mostafa ; Sweya, Lukuba N ; Eriwata, Graham ; Wilkinson, Suzanne ; Khatibi, Hamed. In: Environment and Planning B. RePEc:sae:envirb:v:49:y:2022:i:5:p:1556-1577. Full description at Econpapers || Download paper | |
2022 | . Full description at Econpapers || Download paper | |
2022 | . Full description at Econpapers || Download paper | |
2022 | Do we agree or disagree? A systematic review of the application of preference-based instruments in self and proxy reporting of quality of life in older people. (2022). Hutchinson, Claire ; Worley, Anthea ; Khadka, Jyoti ; Milte, Rachel ; Cleland, Jenny ; Ratcliffe, Julie. In: Social Science & Medicine. RePEc:eee:socmed:v:305:y:2022:i:c:s0277953622003525. Full description at Econpapers || Download paper | |
2022 | Authorsâ Response to âPreoperative Intravenous Iron for Iron Deficiency is Cost-Effective Prior to Major Elective Surgeryâ. (2022). Compernolle, Veerle ; de Buck, Emmy ; van Remoortel, Hans ; Avau, Bert ; Vandekerckhove, Philippe. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:1:d:10.1007_s40273-021-01084-9. Full description at Econpapers || Download paper | |
2022 | Preoperative Intravenous Iron for Iron Deficiency is Cost-Effective Prior to Major Elective Surgery. (2022). Hofmann, Axel ; Mace, Hamish ; Trentino, Kevin M. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:1:d:10.1007_s40273-021-01083-w. Full description at Econpapers || Download paper | |
2022 | Value drivers of development stage biopharma companies. (2022). Yagmur, Hasan Basri ; Michaeli, Daniel Tobias ; Achmadeev, Timur. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:23:y:2022:i:8:d:10.1007_s10198-021-01427-5. Full description at Econpapers || Download paper | |
2022 | A theory of fiscal policy response to an epidemic. (2022). Pang, YU. In: Health Economics. RePEc:wly:hlthec:v:31:y:2022:i:9:p:2050-2071. Full description at Econpapers || Download paper | |
2022 | Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence. (2022). Damiani, Gianfranco ; Dallapiccola, Bruno ; Cicchetti, Americo ; Tartaglia, Marco ; Bertini, Enrico Silvio ; Chillemi, Giovanni ; Radio, Francesca Clementina ; Riccardi, Maria Teresa ; Nurchis, Mario Cesare. In: Health Policy. RePEc:eee:hepoli:v:126:y:2022:i:4:p:337-345. Full description at Econpapers || Download paper | |
2022 | . Full description at Econpapers || Download paper | |
2022 | EQ-5D-Y-3L Value Sets, Valuation Methods and Conceptual Questions. (2022). Stolk, Elly ; Viney, Rosalie ; Roudijk, Bram ; Devlin, Nancy. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01226-7. Full description at Econpapers || Download paper | |
2022 | . Full description at Econpapers || Download paper | |
2022 | Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis. (2022). Welte, Robert ; Fischer, Franz ; Wilke, Thomas ; Kocaata, Zeki ; Einsele, Hermann. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:4:d:10.1007_s41669-022-00344-4. Full description at Econpapers || Download paper | |
2022 | Revisiting the Connection between State Medicaid Expansions and Adult Mortality. (2022). Zapata, Daniela ; Koumpias, Antonios M ; Jones, Jordan ; Courtemanche, Charles. In: IZA Discussion Papers. RePEc:iza:izadps:dp15803. Full description at Econpapers || Download paper | |
2022 | Health and Work Outcomes of Brief Counseling From an EAP in Vermont: Follow-Up Survey Results, Client Satisfaction, and Estimated Cost Savings. (2022). Dickens, Steven P ; Attridge, Mark. In: SAGE Open. RePEc:sae:sagope:v:12:y:2022:i:1:p:21582440221087278. Full description at Econpapers || Download paper | |
2022 | Depression and labor supply: Evidence from the Netherlands. (2022). Rootjes, Frank ; Ringdal, Charlotte. In: Economics & Human Biology. RePEc:eee:ehbiol:v:45:y:2022:i:c:s1570677x21001283. Full description at Econpapers || Download paper | |
2022 | . Full description at Econpapers || Download paper | |
2022 | Marijuana Legalization and Mental Health. (2022). Romiti, Agnese ; Norris, Jonathan ; Lenhart, Otto ; Borbely, Daniel. In: IZA Discussion Papers. RePEc:iza:izadps:dp15729. Full description at Econpapers || Download paper | |
2022 | . Full description at Econpapers || Download paper | |
2022 | . Full description at Econpapers || Download paper | |
2022 | . Full description at Econpapers || Download paper | |
2022 | The consequences of illicit drug use. Estimation, methods and challenges. (2022). Banacu, Cristian Silviu ; Frusinoiu, Paula Stefania. In: Technium Social Sciences Journal. RePEc:tec:journl:v:34:y:2022:i:1:p:472-482. Full description at Econpapers || Download paper | |
2022 | Vaccine and inclusion. (2022). Pongou, Roland ; Tondji, Jeanbaptiste ; Tchantcho, Bertrand ; Nganmeni, Zephirin. In: Journal of Public Economic Theory. RePEc:bla:jpbect:v:24:y:2022:i:5:p:1101-1123. Full description at Econpapers || Download paper | |
2022 | . Full description at Econpapers || Download paper | |
2022 | Market access for medicines treating rare diseases: Association between specialised processes for orphan medicines and funding recommendations. (2022). Fontrier, Anna-Maria. In: Social Science & Medicine. RePEc:eee:socmed:v:306:y:2022:i:c:s0277953622004257. Full description at Econpapers || Download paper | |
2022 | Where do measures of health, social care and wellbeing fit within a wider measurement framework? Implications for the measurement of quality of life and the identification of bolt-ons. (2022). Mulhern, Brendan ; Finch, Aureliano Paolo. In: Social Science & Medicine. RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622006761. Full description at Econpapers || Download paper |
Year | Citing document | |
---|---|---|
2022 | Where do measures of health, social care and wellbeing fit within a wider measurement framework? Implications for the measurement of quality of life and the identification of bolt-ons. (2022). Mulhern, Brendan ; Finch, Aureliano Paolo. In: Social Science & Medicine. RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622006761. Full description at Econpapers || Download paper | |
2022 | The health cost of reducing hospital bed capacity. (2022). Henriksson, Martin ; Siverskog, Jonathan. In: Social Science & Medicine. RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622007055. Full description at Econpapers || Download paper | |
2022 | . Full description at Econpapers || Download paper | |
2022 | . Full description at Econpapers || Download paper | |
2022 | Response to Comment on âAn Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophreniaâ. (2022). Wang, Xiaofeng ; Kraan, Carla W ; Houwing, Natalie ; Piena, Marjanne A ; Bennison, Craig ; Waters, Heidi. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:12:d:10.1007_s40273-022-01213-y. Full description at Econpapers || Download paper | |
2022 | An EQ-5D-Y-3L Value Set for Belgium. (2022). Ramos-Goi, Juan M ; Tollenaar, Nafthali H ; Roudijk, Bram ; Dewilde, Sarah. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01187-x. Full description at Econpapers || Download paper | |
2022 | Value Set for the EQ-5D-Y-3L in Hungary. (2022). Brodszky, Valentin ; Finch, Aureliano Paolo ; Yang, Zhihao ; Bato, Alex ; Ruzsa, Gabor ; Rencz, Fanni. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01190-2. Full description at Econpapers || Download paper | |
2022 | Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L. (2022). Rivero-Arias, Oliver ; Shah, Koonal K ; Norman, Richard ; Kreimeier, Simone ; Devlin, Nancy J ; Mott, David J. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01214-x. Full description at Econpapers || Download paper | |
2022 | Estimating an EQ-5D-Y-3L Value Set for China. (2022). Jing, Mingxia ; Li, Shunping ; Yu, Xiao ; Feng, DA ; Fang, YU ; Wu, Jing ; Wang, Pei ; Luo, Nan ; Jiang, Jie ; Huang, Weidong ; Yang, Zhihao ; Zheng, Bin. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01216-9. Full description at Econpapers || Download paper | |
2022 | Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L. (2022). Gu, Ning Yan ; Pickard, Simon A ; Nazari, Jonathan L. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01222-x. Full description at Econpapers || Download paper | |
2022 | EQ-5D-Y-3L Value Sets, Valuation Methods and Conceptual Questions. (2022). Stolk, Elly ; Viney, Rosalie ; Roudijk, Bram ; Devlin, Nancy. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01226-7. Full description at Econpapers || Download paper | |
2022 | Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China. (2022). Chen, Yixuan ; Li, Huangqianyu ; Wei, Yuxuan ; Zhang, Yichen ; Guan, Xiaodong ; Shi, Luwen ; Guo, Yiran. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:7:d:10.1007_s40273-022-01161-7. Full description at Econpapers || Download paper |
Year | Citing document | |
---|---|---|
2021 | Value judgments in a COVID-19 vaccination model: A case study in the need for public involvement in health-oriented modelling. (2021). Adibi, Amin ; Symons, John ; Winsberg, Eric ; Harvard, Stephanie. In: Social Science & Medicine. RePEc:eee:socmed:v:286:y:2021:i:c:s0277953621006559. Full description at Econpapers || Download paper | |
2021 | . Full description at Econpapers || Download paper | |
2021 | . Full description at Econpapers || Download paper | |
2021 | . Full description at Econpapers || Download paper | |
2021 | . Full description at Econpapers || Download paper | |
2021 | The Health and Productivity Burden of Depression in South Korea. (2021). Ademi, Zanfina ; Liew, Danny ; Rhee, Yongjoo ; Zomer, Ella. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:6:d:10.1007_s40258-021-00649-1. Full description at Econpapers || Download paper | |
2021 | EQ-5D-Y Population Norms for Japanese Children and Adolescents. (2021). Fukuda, Takashi ; Shiroiwa, Takeru. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:11:d:10.1007_s40273-021-01063-0. Full description at Econpapers || Download paper | |
2021 | Health-Economic Analyses of Diagnostics: Guidance on Design and Reporting. (2021). Postma, Maarten J ; Villar, Fernando Antoanzas ; Garcia, Paula Rojas ; Pol, Simon. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:12:d:10.1007_s40273-021-01104-8. Full description at Econpapers || Download paper | |
2021 | Authorsâ Reply to Comment on âCost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndromeâ. (2021). Veenstra, David L ; Carlson, Josh J ; Neuberger, Edward E. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:4:d:10.1007_s40273-021-01006-9. Full description at Econpapers || Download paper | |
2021 | Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States. (2021). Bright, Jennifer L ; Linthicum, Mark T ; Malik, Erica Defur ; Xie, Richard Z. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01036-3. Full description at Econpapers || Download paper | |
2021 | The Growing Burden of Major Depressive Disorders (MDD): Implications for Researchers and Policy Makers. (2021). Nellesen, Dave ; Greenberg, Paul ; Proudman, David. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01040-7. Full description at Econpapers || Download paper |
Year | Citing document | |
---|---|---|
2020 | Health Economics Tools and Precision Medicine: Opportunities and Challenges. (2020). Scott, Ramsey ; Josh, Peterson ; Peter, Neumann ; Jeanne, Mandelblatt ; Anirban, Basu ; David, Veenstra. In: Forum for Health Economics & Policy. RePEc:bpj:fhecpo:v:23:y:2020:i:1:p:14:n:1. Full description at Econpapers || Download paper | |
2020 | Systematic review of the methods of health economic models assessing antipsychotic medication for schizophrenia. (2020). Byford, Sarah ; Aceituno, David ; Achilla, Evanthia ; Robinson, Stewart ; Tappenden, Paul ; Jin, Huajie. In: PLOS ONE. RePEc:plo:pone00:0234996. Full description at Econpapers || Download paper | |
2020 | Stakeholder-Engaged Derivation of Patient-Informed Value Elements. (2020). Dosreis, Susan ; Slejko, Julia F ; Zhang, Chengchen ; Hong, Yoon Duk ; Kennedy, Annie ; Caicedo, Juan ; Butler, Beverly. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:13:y:2020:i:5:d:10.1007_s40271-020-00433-8. Full description at Econpapers || Download paper | |
2020 | External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions. (2020). Johansen, Pierre ; Lamotte, Mark ; Lopes, Sandra ; Foos, Volker ; Olivieri, Anamaria-Vera ; McEwan, Phil. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:10:d:10.1007_s40273-020-00941-3. Full description at Econpapers || Download paper | |
2020 | Reflections on NICEâs Uptake of New Methods: Past, Present, and the 2020 Review. (2020). Watson, Ian ; Boysen, Meindert. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:3:d:10.1007_s40273-020-00888-5. Full description at Econpapers || Download paper | |
2020 | Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of BestâWorst Scaling. (2020). Gorostiza, Inigo ; Garcia-Lorenzo, Borja ; Catchpool, Max ; Dalziel, Kim ; Rivero-Arias, Oliver ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:5:d:10.1007_s40273-020-00884-9. Full description at Econpapers || Download paper | |
2020 | Response to Comment on âFluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-Infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisalâ. (2020). Denniston, Alastair K ; Carrera, Vanesa Huertas ; Joore, Manuela A ; Petersohn, Svenja ; Kleijnen, Jos ; Riemsma, Rob ; Noake, Caro ; Worthy, Gill ; Witlox, Willem ; Armstrong, Nigel ; Raatz, Heike ; Chalker, Annette. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:6:d:10.1007_s40273-020-00900-y. Full description at Econpapers || Download Replacing the NCCNâs Blocks with Wheels: How Should Consideration of Societal Spending be Incorporated into Oncology Practice?. (2020). Prasad, Vinay ; Tran, Audrey A. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00920-8. Full description at Econpapers || Download paper | |
2020 | What Value Does the NCCN Affordability Rating Really Provide to Patients, Providers, and Society?. (2020). McQueen, Brett R. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00924-4. Full description at Econpapers || Download paper | |
2020 | Why itâs Time to Abandon the ICER. (2020). Paulden, Mike. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00915-5. Full description at Econpapers || Download paper | |
2020 | Does Cost-Effectiveness Analysis Really Need to Abandon the Incremental Cost-Effectiveness Ratio to Embrace Net Benefit?. (2020). Omahony, James F. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00931-5. Full description at Econpapers || Download paper | |
2020 | Keeping Pace with Pharmaceutical Innovation: The Importance of the NICE Methods Review. (2020). Barrett, Victoria ; Catchpole, Paul. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:9:d:10.1007_s40273-020-00918-2. Full description at Econpapers || Download paper | |
2020 | Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review. (2020). Mattingly, T. Joseph ; Khokhar, Bilal ; Love, Bryan L. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:9:d:10.1007_s40273-020-00933-3. Full description at Econpapers || Download paper |
Year | Citing document | |
---|---|---|
2019 | Insight of Artificial Intelligence Application in Healthcare. (2019). Kuang, Cedric. In: International Journal of Sciences. RePEc:adm:journl:v:8:y:2019:i:8:p:50-55. Full description at Econpapers || Download paper | |
2019 | . Full description at Econpapers || Download paper | |
2019 | . Full description at Econpapers || Download paper | |
2019 | Discrete Choice under Oaths. (2019). Watson, Verity ; Shogren, Jason ; Jacquemet, Nicolas ; Luchini, Stephane. In: Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers). RePEc:hal:cesptp:halshs-02136103. Full description at Econpapers || Download paper | |
2019 | Discrete Choice under Oaths. (2019). Shogren, Jason ; Jacquemet, Nicolas ; Watson, Verity ; Luchini, Stephane. In: Post-Print. RePEc:hal:journl:halshs-02136103. Full description at Econpapers || Download paper | |
2019 | Discrete Choice under Oaths. (2019). Shogren, Jason ; Jacquemet, Nicolas ; Watson, Verity ; Luchini, Stephane. In: Working Papers. RePEc:hal:wpaper:halshs-02136103. Full description at Econpapers || Download paper | |
2019 | Discrete Choice under Oaths. (2019). Watson, Verity ; Shogren, Jason ; Jacquemet, Nicolas ; Luchini, Stephane. In: Documents de travail du Centre d'Economie de la Sorbonne. RePEc:mse:cesdoc:19007. Full description at Econpapers || Download paper | |
2019 | Public Preferences for Health Gains and Cures: A Discrete Choice Experiment. (2019). Shah, Koonal ; Mott, David ; Hampson, Grace ; Devlin, Nancy. In: Consulting Reports. RePEc:ohe:conrep:002108. Full description at Econpapers || Download paper | |
2019 | Value of information analysis in telehealth for chronic heart failure management. (2019). Severens, Johan L ; Koymans, Ron ; Buyukkaramikli, Nasuh ; Grustam, Andrija S. In: PLOS ONE. RePEc:plo:pone00:0218083. Full description at Econpapers || Download paper | |
2019 | The burden of informal caregiving in Hungary, Poland and Slovenia: results from national representative surveys. (2019). Brouwer, Werner ; Baji, Petra ; Prevolnik-Rupel, Valentina ; Golicki, Dominik ; Pentek, Marta ; Gulacsi, Laszlo ; Zrubka, Zsombor. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:1:d:10.1007_s10198-019-01058-x. Full description at Econpapers || Download paper | |
2019 | Attribute development and level selection for a discrete choice experiment to elicit the preferences of health care providers for capitation payment mechanism in Kenya. (2019). Abiiro, Gilbert Abotisem ; Kazungu, Jacob ; Barasa, Edwine ; Obadha, Melvin ; Chuma, Jane. In: Health Economics Review. RePEc:spr:hecrev:v:9:y:2019:i:1:d:10.1186_s13561-019-0247-5. Full description at Econpapers || Download paper | |
2019 | Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States. (2019). Chapman, Richard H ; Basu, Anirban ; Walton, Surrey M ; Carlson, Josh J ; Ollendorf, Daniel A ; Whittington, Melanie D ; Veenstra, David ; Touchette, Daniel R ; Pearson, Steven D ; McQueen, Brett R ; Campbell, Jonathan D. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:11:d:10.1007_s40273-019-00832-2. Full description at Econpapers || Download Improving Transparency in Decision Models: Current Issues and Potential Solutions. (2019). Caro, Jaime J ; Tappenden, Paul. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:11:d:10.1007_s40273-019-00850-0. Full description at Econpapers || Download paper | |
2019 | Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part IIâAn Updated Analysis of SEER-Medicare Data. (2019). Shih, Ya-Chen ; Chien, Chun-Ru ; Xu, Ying ; Geynisman, Daniel M ; Li, Liang ; Shen, YU ; Kim, Bumyang. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:12:d:10.1007_s40273-019-00824-2. Full description at Econpapers || Download paper | |
2019 | Spillover Effects on Caregiversâ and Family Membersâ Utility: A Systematic Review of the Literature. (2019). Prosser, Lisa A ; James, Lyndon P ; Wittenberg, Eve. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00768-7. Full description at Econpapers || Download paper | |
2019 | Advances in Methods and Novel Applications for Measuring Family Spillover Effects of Illness. (2019). Wittenberg, Eve ; Prosser, Lisa A. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00794-5. Full description at Econpapers || Download paper | |
2019 | Response to âComment on âCost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United Statesââ. (2019). Fisher, Mark ; Walder, Lydia ; Guy, Holly. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:7:d:10.1007_s40273-019-00803-7. Full description at Econpapers || Download paper | |
2019 | U.K. utility weights for the EORTC QLUââ¬ÂC10D. (2019). Viney, Rosalie ; Street, Deborah J ; Pickard, Simon A ; Cella, David ; Brazier, John E ; Rowen, Donna ; Consortium, The Mauca ; Merciecabebber, Rebecca ; Of, Treatment ; Norman, Richard ; King, Madeleine T ; Revicki, Dennis. In: Health Economics. RePEc:wly:hlthec:v:28:y:2019:i:12:p:1385-1401. Full description at Econpapers || Download paper |